Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Nov-24 8:00 PM View:  | Bridgebio Pharma, Inc. (BBIO) | 19-Nov-24 | Private Sale (Planned) | 27,389 | $22.41 | $613,826.00 | (< 1%) 6.93M to 6.91M | |
| 19-Nov-24 6:15 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-24 | Payment of Exercise | 28,148 | $23.72 | $667,671.00 | (< 1%) 6.96M to 6.93M | |
| 19-Nov-24 6:15 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-24 | Option Exercise | 55,537 | -- | -- | < 1% 6.91M to 6.96M | |
| 20-Aug-24 6:31 PM View: | Bridgebio Pharma, Inc. (BBIO) | 19-Aug-24 | Planned Option Sale | 27,389 | $24.69 | $676,256.00 | (< 1%) 6.93M to 6.91M | |
| 20-Aug-24 6:31 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-24 | Payment of Exercise | 28,148 | $24.40 | $686,811.00 | (< 1%) 6.96M to 6.93M | |
| 20-Aug-24 6:31 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-24 | Option Exercise | 55,537 | -- | -- | < 1% 6.91M to 6.96M | |
| 17-May-24 4:11 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-24 | Payment of Exercise | 30,748 | $31.04 | $954,418.00 | (< 1%) 6.94M to 6.91M | |
| 17-May-24 4:11 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-24 | Option Exercise | 60,667 | -- | -- | < 1% 6.88M to 6.94M | |
| 21-Feb-24 4:03 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-24 | Payment of Exercise | 47,922 | $37.21 | $1,783,180.00 | (< 1%) 6.92M to 6.88M | |
| 21-Feb-24 4:03 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-24 | Option Exercise | 102,249 | -- | -- | 1% 6.82M to 6.92M | |
| 20-Nov-23 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 17-Nov-23 | Planned Option Sale | 51,552 | $29.10 | $1,500,040.00 | (< 1%) 6.87M to 6.82M | |
| 20-Nov-23 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-23 | Payment of Exercise | 50,697 | $28.86 | $1,463,120.00 | (< 1%) 6.92M to 6.87M | |
| 20-Nov-23 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-23 | Option Exercise | 102,249 | -- | -- | 1% 6.82M to 6.92M | |
| 18-Aug-23 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 17-Aug-23 | Planned Option Sale | 51,552 | $28.59 | $1,473,780.00 | (< 1%) 6.87M to 6.82M | |
| 18-Aug-23 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-23 | Payment of Exercise | 50,698 | $29.80 | $1,510,800.00 | (< 1%) 6.92M to 6.87M | |
| 18-Aug-23 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-23 | Option Exercise | 102,250 | -- | -- | 1% 6.82M to 6.92M | |
| 18-May-23 4:07 PM View: | Bridgebio Pharma, Inc. (BBIO) | 17-May-23 | Planned Option Sale | 51,552 | $14.01 | $722,218.00 | (< 1%) 6.87M to 6.82M | |
| 18-May-23 4:07 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-23 | Payment of Exercise | 50,697 | $14.09 | $714,321.00 | (< 1%) 6.92M to 6.87M | |
| 18-May-23 4:07 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-23 | Option Exercise | 102,249 | -- | -- | 1% 6.82M to 6.92M | |
| 05-May-23 4:03 PM View: | Bridgebio Pharma, Inc. (BBIO) | 03-May-23 | Market Sale (Planned) | 120,000 | $14.18 | $1,701,740.00 | (2%) 6.94M to 6.82M | (< 1%) |
| 07-Apr-23 4:39 PM View: | Bridgebio Pharma, Inc. (BBIO) | 05-Apr-23 | Private Sale (Planned) | 120,000 | $15.46 | $1,855,660.00 | (2%) 7.06M to 6.94M | |
| 03-Mar-23 10:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 03-Mar-23 | Sale (Planned) | 120,000 | $10.96 | $1,315,220.00 | (2%) 7.18M to 7.06M | |
| 21-Feb-23 8:12 PM View: | Bridgebio Pharma, Inc. (BBIO) | 17-Feb-23 | Planned Option Sale | 44,798 | $12.70 | $569,074.00 | (< 1%) 7.23M to 7.18M | |
| 21-Feb-23 8:12 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-23 | Payment of Exercise | 23,908 | $12.64 | $302,197.00 | (< 1%) 7.25M to 7.23M | |
| 21-Feb-23 8:12 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-23 | Option Exercise | 68,706 | -- | -- | < 1% 7.18M to 7.25M | |
| 06-Feb-23 7:26 PM View: | Bridgebio Pharma, Inc. (BBIO) | 03-Feb-23 | Sale (Planned) | 120,000 | $11.01 | $1,320,700.00 | (2%) 7.3M to 7.18M | |
| 06-Jan-23 8:35 PM View: | Bridgebio Pharma, Inc. (BBIO) | 05-Jan-23 | Sale (Planned) | 120,000 | $7.67 | $920,856.00 | (2%) 7.42M to 7.3M | |
| 21-Dec-22 7:58 PM View: | Bridgebio Pharma, Inc. (BBIO) | 21-Dec-22 | Sale | 200,000 | -- | -- | (3%) 7.62M to 7.42M | |
| 18-Nov-22 6:42 PM View: | Bridgebio Pharma, Inc. (BBIO) | 17-Nov-22 | Option Sale | 34,640 | $9.40 | $325,606.00 | (< 1%) 7.66M to 7.62M | |
| 18-Nov-22 6:42 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-22 | Payment of Exercise | 34,066 | $9.64 | $328,396.00 | (< 1%) 7.69M to 7.66M | |
| 18-Nov-22 6:42 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-22 | Option Exercise | 68,706 | -- | -- | < 1% 7.62M to 7.69M | |
| 18-Aug-22 6:39 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-22 | Payment of Exercise | 27,697 | $11.08 | $306,883.00 | (< 1%) 7.65M to 7.62M | |
| 18-Aug-22 6:39 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-22 | Option Exercise | 68,705 | -- | -- | < 1% 7.58M to 7.65M | |
| 18-May-22 4:06 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-22 | Payment of Exercise | 23,759 | $6.74 | $160,136.00 | (< 1%) 7.6M to 7.58M | |
| 18-May-22 4:06 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-22 | Option Exercise | 68,705 | -- | -- | < 1% 7.54M to 7.6M | |
| 18-Feb-22 4:35 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-22 | Payment of Exercise | 3,085 | $8.84 | $27,271.40 | (< 1%) 7.54M to 7.54M | |
| 18-Feb-22 4:35 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-22 | Option Exercise | 7,524 | -- | -- | < 1% 7.53M to 7.54M | |
| 18-Nov-21 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-21 | Payment of Exercise | 3,730 | $47.25 | $176,242.00 | (< 1%) 7.53M to 7.53M | |
| 18-Nov-21 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-21 | Option Exercise | 7,523 | -- | -- | < 1% 7.53M to 7.53M | |
| 18-Aug-21 4:06 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-21 | Payment of Exercise | 3,730 | $49.48 | $184,560.00 | (< 1%) 7.53M to 7.53M | |
| 18-Aug-21 4:06 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-21 | Option Exercise | 7,523 | -- | -- | < 1% 7.52M to 7.53M | |
| 18-May-21 6:29 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-21 | Payment of Exercise | 3,731 | $53.66 | $200,205.00 | (< 1%) 7.53M to 7.52M | |
| 18-May-21 6:29 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-21 | Option Exercise | 7,524 | -- | -- | < 1% 7.52M to 7.53M | |
| 18-Feb-21 7:45 PM View: | Bridgebio Pharma, Inc. (BBIO) | 17-Feb-21 | Payment of Exercise | 16,000 | $62.50 | $1,000,000.00 | < 1% 7.5M to 7.52M | |
| 18-Feb-21 7:45 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-21 | Payment of Exercise | 2,139 | $64.98 | $138,992.00 | (< 1%) 7.51M to 7.5M | |
| 18-Feb-21 7:45 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-21 | Option Exercise | 5,129 | -- | -- | < 1% 7.5M to 7.51M | |
| 12-Feb-21 10:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 24-Nov-20 | Gift | 268,000 | -- | -- | 3% 7.71M to 7.97M | |
| 12-Feb-21 10:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 24-Nov-20 | Gift | 472,650 | -- | -- | (6%) 7.97M to 7.5M | |
| 18-Nov-20 7:51 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-20 | Payment of Exercise | 1,774 | $44.33 | $78,641.40 | (< 1%) 7.71M to 7.71M | |
| 18-Nov-20 7:51 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-20 | Option Exercise | 5,129 | -- | -- | < 1% 7.7M to 7.71M |